Trivarx Ltd (TRI) - Total Liabilities
Based on the latest financial reports, Trivarx Ltd (TRI) has total liabilities worth AU$771.99K AUD (≈ $546.23K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Trivarx Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Trivarx Ltd - Total Liabilities Trend (2001–2025)
This chart illustrates how Trivarx Ltd's total liabilities have evolved over time, based on quarterly financial data. See TRI FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Trivarx Ltd Competitors by Total Liabilities
The table below lists competitors of Trivarx Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
MYMBN Berhad
KLSE:0280
|
Malaysia | RM8.77 Million |
|
RENEWABLE VENTURES NORDIC
F:X72
|
Germany | €197.73K |
|
Asia Seed Co.Ltd
KQ:154030
|
Korea | ₩16.44 Billion |
|
Mont Royal Resources Ltd
AU:MRZ
|
Australia | AU$382.34K |
|
Intrasense
PA:ALINS
|
France | €14.45 Million |
|
Herkules S.A.
WAR:HRS
|
Poland | zł152.01 Million |
|
MedX Health Corp
V:MDX
|
Canada | CA$11.28 Million |
|
Jasper Therapeutics Inc
NASDAQ:JSPR
|
USA | $17.78 Million |
Liability Composition Analysis (2001–2025)
This chart breaks down Trivarx Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Trivarx Ltd stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.45 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.03 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Trivarx Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Trivarx Ltd (2001–2025)
The table below shows the annual total liabilities of Trivarx Ltd from 2001 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$831.22K ≈ $588.14K |
-29.83% |
| 2024-06-30 | AU$1.18 Million ≈ $838.21K |
-32.67% |
| 2023-06-30 | AU$1.76 Million ≈ $1.24 Million |
+27.33% |
| 2022-06-30 | AU$1.38 Million ≈ $977.73K |
+43.39% |
| 2021-06-30 | AU$963.68K ≈ $681.86K |
-31.37% |
| 2020-06-30 | AU$1.40 Million ≈ $993.55K |
-70.12% |
| 2019-06-30 | AU$4.70 Million ≈ $3.32 Million |
-7.46% |
| 2018-06-30 | AU$5.08 Million ≈ $3.59 Million |
-14.46% |
| 2017-06-30 | AU$5.94 Million ≈ $4.20 Million |
-37.03% |
| 2016-06-30 | AU$9.43 Million ≈ $6.67 Million |
+55.21% |
| 2015-06-30 | AU$6.07 Million ≈ $4.30 Million |
+160.41% |
| 2014-06-30 | AU$2.33 Million ≈ $1.65 Million |
-19.04% |
| 2013-06-30 | AU$2.88 Million ≈ $2.04 Million |
-4.99% |
| 2012-06-30 | AU$3.03 Million ≈ $2.15 Million |
+44.43% |
| 2011-06-30 | AU$2.10 Million ≈ $1.49 Million |
+574.97% |
| 2010-06-30 | AU$311.02K ≈ $220.06K |
+18.60% |
| 2009-06-30 | AU$262.24K ≈ $185.55K |
-47.24% |
| 2008-06-30 | AU$497.07K ≈ $351.71K |
+176.43% |
| 2007-06-30 | AU$179.82K ≈ $127.23K |
-2.26% |
| 2006-06-30 | AU$183.98K ≈ $130.18K |
-23.21% |
| 2005-06-30 | AU$239.59K ≈ $169.52K |
-13.49% |
| 2004-06-30 | AU$276.96K ≈ $195.96K |
-3.70% |
| 2003-06-30 | AU$287.58K ≈ $203.48K |
-68.49% |
| 2002-06-30 | AU$912.54K ≈ $645.68K |
-4.12% |
| 2001-06-30 | AU$951.79K ≈ $673.45K |
-- |
About Trivarx Ltd
TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Med… Read more